1.8(top 50%)
impact factor
1.1K(top 20%)
papers
10.3K(top 20%)
citations
39(top 20%)
h-index
1.9(top 50%)
impact factor
1.4K
all documents
11.3K
doc citations
66(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Personalized Medicine2011507
2P4 medicine: how systems medicine will transform the healthcare sector and societyPersonalized Medicine2013422
3Wearables and the medical revolutionPersonalized Medicine2018361
4Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobankPersonalized Medicine2005196
5Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncologyPersonalized Medicine2010155
6The Googlization of health research: from disruptive innovation to disruptive ethicsPersonalized Medicine2016105
7Individual genomes and personalized medicine: life diversity and complexityPersonalized Medicine2010100
8Biobanking in British Columbia: discussions of the future of personalized medicine through deliberative public engagementPersonalized Medicine200896
9Strategies for integrating personalized medicine into healthcare practicePersonalized Medicine201793
10Genotype–environment interactions and their translational implicationsPersonalized Medicine201184
11'Personalized medicine': what’s in a name?Personalized Medicine201482
12Pharmacogenomics steps toward personalized medicinePersonalized Medicine200572
13A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapyPersonalized Medicine201271
14Eyes wide open: the personal genome project, citizen science and veracity in informed consentPersonalized Medicine200968
15Clinician perspectives on using pharmacogenomics in clinical practicePersonalized Medicine201567
16Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testingPersonalized Medicine201266
17Community pharmacists‘ attitudes towards clinical utility and ethical implications of pharmacogenetic testingPersonalized Medicine201365
18Translational systems biology of inflammation: potential applications to personalized medicinePersonalized Medicine201061
19Ethical, legal and social implications of incorporating personalized medicine into healthcarePersonalized Medicine201560
20Nutrigenomics and personalized nutrition: science and conceptPersonalized Medicine200857
21Personalized medicine: challenges and opportunities for translational bioinformaticsPersonalized Medicine201357
22Coriell Personalized Medicine Collaborative®: a prospective study of the utility of personalized medicinePersonalized Medicine201055
23Market access challenges in the EU for high medical value diagnostic testsPersonalized Medicine201153
24Influence ofCYP2C9genotype on warfarin dose among African–Americans and European–AmericansPersonalized Medicine200752
25Individualizing warfarin therapyPersonalized Medicine200751
26Unraveling human complexity and disease with systems biology and personalized medicinePersonalized Medicine201050
27After the revolution? Ethical and social challenges in ‘personalized genomic medicine’Personalized Medicine201250
28Primary care physician experiences with integrated pharmacogenomic testing in a community health systemPersonalized Medicine201749
29Genomic information as a behavioral health intervention: can it work?Personalized Medicine201148
30A critical view of the general public’s awareness and physicians’ opinion of the trends and potential pitfalls of genetic testing in GreecePersonalized Medicine201147
31Genetic susceptibility to bladder cancer risk and outcomePersonalized Medicine201146
32Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in GreecePersonalized Medicine201446
33US FDA and personalized medicine: in vitro diagnostic regulatory perspectivePersonalized Medicine201045
34Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcarePersonalized Medicine201245
35HLA-Bgenotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicinePersonalized Medicine200544
36National nursing workforce survey of nursing attitudes, knowledge and practice in genomicsPersonalized Medicine201344
37Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payersPersonalized Medicine201344
38Direct-to-consumer genetic testing: where and how does genetic counseling fit?Personalized Medicine201744
39Personhood and solidarity: what kind of personalized medicine do we want?Personalized Medicine201443
40Knowledge and attitudes concerning pharmacogenomics among healthcare professionalsPersonalized Medicine201140
41The road from next-generation sequencing to personalized medicinePersonalized Medicine201440
42‘Someday it will be the norm’: physician perspectives on the utility of genome sequencing for patient care in the MedSeqProjectPersonalized Medicine201540
43Machine learning for biomarker identification in cancer research – developments toward its clinical applicationPersonalized Medicine201540
44Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physiciansPersonalized Medicine201239
45Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicinePersonalized Medicine201839
46The unintended implications of blurring the line between research and clinical care in a genomic agePersonalized Medicine201438
47Quo vadis personalized medicine?Personalized Medicine200437
48Genetics, genomics and society: the responsibilities of scientists for science communication and educationPersonalized Medicine201236
49Genetics patients’ perspectives on clinical genomic testingPersonalized Medicine201336
50Medical student preparedness for an era of personalized medicine: findings from one US medical schoolPersonalized Medicine201636